Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frier

Showing results (401-410 of 442) with videos related to

Pageof 45
Sort By:
Diabetes Care|October 4, 2013
Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyBerit Inkster, Renata L Riha, Liesbeth Van Look, et al.
Open Heart|September 16, 2017
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitusRadzi M Noh, Sowmya Venkatasubramanian, Shruti Daga, et al.
Diabetologia|April 8, 2015
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetesInsa Feinkohl, Markéta Keller, Christine M Robertson, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2001
Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjectsA C Perkins, C G Wilson, M Frier, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2005
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based studyL A Donnelly, A D Morris, B M Frier, et al.
British Journal of Obstetrics and Gynaecology|July 30, 1999
An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinomaQ Davies, A C Perkins, J C Roos, et al.
International Journal of Pharmaceutics|September 16, 1999
Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulationsA C Perkins, C G Wilson, M Frier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595O D Hughes, M C Bishop, A C Perkins, et al.
International Journal of Pharmaceutics|June 28, 2001
The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of waterA C Perkins, C G Wilson, M Frier, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Effect of hypoglycaemia on measures of myocardial blood flow and myocardial injury in adults with and without type 1 diabetes: A prospective, randomised, open-label, blinded endpoint, cross-over studyRadzi M Noh, Alex J Graveling, Ninian N Lang, et al.
Pageof 45

Showing results (401-410 of 442) with videos related to

Sort By:
Pageof 45
Diabetes Care|October 4, 2013
Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyBerit Inkster, Renata L Riha, Liesbeth Van Look, et al.
Open Heart|September 16, 2017
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitusRadzi M Noh, Sowmya Venkatasubramanian, Shruti Daga, et al.
Diabetologia|April 8, 2015
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetesInsa Feinkohl, Markéta Keller, Christine M Robertson, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2001
Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjectsA C Perkins, C G Wilson, M Frier, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2005
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based studyL A Donnelly, A D Morris, B M Frier, et al.
British Journal of Obstetrics and Gynaecology|July 30, 1999
An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinomaQ Davies, A C Perkins, J C Roos, et al.
International Journal of Pharmaceutics|September 16, 1999
Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulationsA C Perkins, C G Wilson, M Frier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595O D Hughes, M C Bishop, A C Perkins, et al.
International Journal of Pharmaceutics|June 28, 2001
The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of waterA C Perkins, C G Wilson, M Frier, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Effect of hypoglycaemia on measures of myocardial blood flow and myocardial injury in adults with and without type 1 diabetes: A prospective, randomised, open-label, blinded endpoint, cross-over studyRadzi M Noh, Alex J Graveling, Ninian N Lang, et al.
Pageof 45